New study aims to boost IUI success with a simple, fixed hormone dose
NCT ID NCT07153367
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial is testing whether a fixed dose of the hormone follitropin delta (Rekovelle) can improve ovarian stimulation for intrauterine insemination (IUI) in women with regular cycles. The goal is to promote the growth of two mature eggs per cycle to increase pregnancy chances while minimizing the risk of multiple pregnancies. Eighty participants aged 18-38 will receive the same dose and be monitored closely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
follitropin delta (Rekovelle)
What this could lead to
If successful, this could offer a simpler, more effective starting dose for ovarian stimulation in intrauterine insemination, potentially increasing pregnancy rates while lowering the risk of multiple births.
What could go wrong
This is a small Phase 2 trial with only 80 participants, so results may not apply to all patients. The fixed dose may not work for everyone, and there is still a risk of ovarian hyperstimulation or multiple pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabinet Dr Elodie Descat-Polyclinique Jean Villar
RECRUITINGBruges, 33520, France
Contact Email: •••••@•••••
Contact
-
Cabinet Dr Géraldine PORCU-Institut de Médecine de la Reproduction
RECRUITINGMarseille, 13008, France
Contact Email: •••••@•••••
Contact
-
Cabinet Dr Nathalie Massin- Hôpital Américain De Paris
SUSPENDEDNeuilly-sur-Seine, 92200, France
-
Cabinet Dr Nicolas Chevalier-Centre AMP Saint Roch
RECRUITINGMontpellier, 34070, France
Contact Email: •••••@•••••
Contact
-
Chi Creteil
RECRUITINGCréteil, 94000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact